Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the Vaccine Safety Datalink

被引:1
|
作者
Kenigsberg, Tat'Yana A. [1 ]
Hause, Anne M. [1 ]
McNeil, Michael M. [1 ]
Nelson, Jennifer C. [2 ]
Shoup, Jo Ann [3 ]
Goddard, Kristin [4 ]
Lou, Yingbo [5 ]
Hanson, Kayla E. [6 ]
Glenn, Sungching C. [7 ]
Weintraub, Eric S. [1 ]
机构
[1] Ctr Dis Control & Prevent, 1600 Clifton Rd,MS V18-4, Atlanta, GA 30329 USA
[2] Kaiser Permanente Washington Res Inst, Seattle, WA USA
[3] Kaiser Permanente, Inst Hlth Res, Denver, CO USA
[4] Kaiser Permanente Northern Calif, Oakland, CA USA
[5] Denver Hlth, Denver, CO USA
[6] Marshfield Clin Res Inst, Marshfield, WI USA
[7] Kaiser Permanente Southern Calif, Pasadena, CA USA
关键词
Data visualization; Vaccines; Public health surveillance;
D O I
10.1016/j.vaccine.2022.04.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Vaccine Safety Datalink (VSD) conducts active surveillance and vaccine safety research studies. Since the start of the U.S. COVID-19 vaccination program, the VSD has conducted near real-time safety surveillance of COVID-19 vaccines using Rapid Cycle Analysis. VSD investigators developed an internal dashboard to facilitate visualization and rapid reviews of large weekly automated vaccine safety surveillance data. Dashboard development and maintenance was informed by vaccine surveillance data users and vaccine safety partners. Key metrics include population demographics, vaccine uptake, pre specified safety outcomes, sequential analyses results, and descriptive data on potential vaccine safety signals. Dashboard visualizations are used to provide situational awareness on dynamic vaccination coverage and the status of multiple safety analyses conducted among the VSD population. This report describes the development and implementation of the internal VSD COVID-19 Vaccine Dashboard, including metrics used to develop the dashboard, which may have application across various other public health settings. Published by Elsevier Ltd.
引用
收藏
页码:3064 / 3071
页数:8
相关论文
共 50 条
  • [1] Near Real-Time Surveillance for Influenza Vaccine Safety: Proof-of-Concept in the Vaccine Safety Datalink Project
    Greene, Sharon K.
    Kulldorff, Martin
    Lewis, Edwin M.
    Li, Rong
    Yin, Ruihua
    Weintraub, Eric S.
    Fireman, Bruce H.
    Lieu, Tracy A.
    Nordin, James D.
    Glanz, Jason M.
    Baxter, Roger
    Jacobsen, Steven J.
    Broder, Karen R.
    Lee, Grace M.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2010, 171 (02) : 177 - 188
  • [2] Do delays in data availability limit the implementation of near real-time vaccine safety surveillance using the Clinical Practice Research Datalink?
    Leite, Andreia
    Thomas, Sara L.
    Andrews, Nick J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 (01) : 25 - 29
  • [3] Tree-based data mining for safety assessment of first COVID-19 booster doses in the Vaccine Safety Datalink
    Yih, Katherine
    Daley, Matthew F.
    Duffy, Jonathan
    Fireman, Bruce
    McClure, David
    Nelson, Jennifer
    Qian, Lei
    Smith, Ning
    Vazquez-Benitez, Gabriela
    Weintraub, Eric
    Williams, Joshua T. B.
    Xu, Stanley
    Maro, Judith C.
    VACCINE, 2023, 41 (02) : 460 - 466
  • [4] Overview of US COVID-19 vaccine safety surveillance systems☆
    Gee, Julianne
    Shimabukuro, Tom T.
    Su, John R.
    Shay, David
    Ryan, Margaret
    Basavaraju, Sridhar V.
    Broder, Karen R.
    Clark, Matthew
    Creech, C. Buddy
    Cunningham, Francesca
    Goddard, Kristin
    Guy, Harrison
    Edwards, Kathryn M.
    Forshee, Richard
    Hamburger, Tanya
    Hause, Anne M.
    Klein, Nicola P.
    Kracalik, Ian
    Lamer, Chris
    Loran, David A.
    Mcneil, Michael M.
    Montgomery, Jay
    Moro, Pedro
    Myers, Tanya R.
    Olson, Christine
    Oster, Matthew E.
    Sharma, Andrea J.
    Schupbach, Ryan
    Weintraub, Eric
    Whitehead, Brett
    Anderson, Steven
    VACCINE, 2024, 42
  • [5] Attitudes and beliefs regarding COVID-19 and COVID-19 Omicron booster vaccine among adults in the vaccine safety datalink, 2022-2023
    Hurley, Laura P.
    Kurlandsky, Kate
    Breslin, Kristin
    Stein, Amy
    Hambidge, Simon J.
    Shoup, Jo Ann
    Reifler, Liza M.
    Daley, Matthew F.
    Lewin, Bruno
    Goddard, Kristin
    Henninger, Michelle L.
    Nelson, Jennifer C.
    Vazquez-Benitez, Gabriela
    Hanson, Kayla E.
    Fuller, Candace C.
    Williams, Joshua T. B.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2025, 21 (01)
  • [6] Data and Safety Monitoring of COVID-19 Vaccine Clinical Trials
    Joffe, Steven
    Babiker, Abdel
    Ellenberg, Susan S.
    Fix, Alan
    Griffin, Marie R.
    Hunsberger, Sally
    Kalil, Jorge
    Levine, Myron M.
    Makgoba, Malegapuru W.
    Moore, Renee H.
    Tsiatis, Anastasios A.
    Whitley, Richard
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (12) : 1995 - 2000
  • [7] Assessing recording delays in general practice records to inform near real-time vaccine safety surveillance using the Clinical Practice Research Datalink (CPRD)
    Leite, Andreia
    Andrews, Nick J.
    Thomas, Sara L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 (04) : 437 - 445
  • [8] A framework for nationwide COVID-19 vaccine safety research in the Republic of Korea: the COVID-19 Vaccine Safety Research Committee
    Jeong, Na-Young
    Park, Hyesook
    Oh, Sanghoon
    Jung, Seung Eun
    Kim, Dong-Hyun
    Shin, Hyoung-Shik
    Han, Hee Chul
    Lee, Jong-Koo
    Woo, Jun Hee
    Park, Byung-Joo
    Choi, Nam-Kyong
    OSONG PUBLIC HEALTH AND RESEARCH PERSPECTIVES, 2023, 14 (01) : 5 - 14
  • [9] Implementing near real-time vaccine safety surveillance using the Clinical Practice Research Dataiink (CPRD)
    Leite, Andreia
    Thomas, Sara L.
    Andrews, Nick J.
    VACCINE, 2017, 35 (49) : 6885 - 6892
  • [10] Scrutinizing the COVID-19 vaccine safety debate
    Bin Abdulrahman, Khalid
    Bin Abdulrahman, Amro
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)